| 靶点: |
Dihydropyrimidine dehydrogenase. |
| 体内研究: |
Eniluracil (5-Ethynyluracil) (1 mg/kg; i.p.; single daily for 3 days) exhibits neither toxicity nor intrinsic antitumor activity, and greatly improves FUra (5-fluorouracil) therapy in rats. |
| 参考文献: |
1. Cao S, et al. 5-Ethynyluracil (776C85): modulation of 5-fluorouracil efficacy and therapeutic index in rats bearing advanced colorectal carcinoma. Cancer Res. 1994 Mar 15;54(6):1507-10. 2. Schilsky RL, et al. Eniluracil: an irreversible inhibitor of dihydropyrimidine dehydrogenase. Expert Opin Investig Drugs. 2000 Jul;9(7):1635-49. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
7.347 ml |
36.735 ml |
73.47 ml |
| 5 mM |
1.469 ml |
7.347 ml |
14.694 ml |
| 10 mM |
0.735 ml |
3.673 ml |
7.347 ml |
| 50 mM |
0.147 ml |
0.735 ml |
1.469 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |